13/10/2025 21:11
|
Medical, Health & Aged Care
Breakthrough designation based on early, positive results of a Phase 1/2 study of sonrotoclax in patients with relapsed or refractory mantle cell lymphoma (MCL)
BeOne to participate in Project...